Michél Laverdière

Voriconazole Compared with Liposomal Amphotericin B for Empirical Antifungal Therapy in Patients with Neutropenia and Persistent Fever

Thomas J. Walsh, Peter G. Pappas, Drew J. Winston et al. · New England Journal of Medicine · 2002 · 985 citations · Full text

Frequency and Evolution of Azole Resistance in<i>Aspergillus fumigatus</i>Associated with Treatment Failure1

Susan J. Howard, Daša Cerar, Michael J. Anderson et al. · Emerging infectious diseases · 2009 · 738 citations · Full text

Antifungal Therapy Decreases Sensitivity of theAspergillus Galactomannan Enzyme Immunoassay

Kieren A. Marr, Michél Laverdière, Anja Gugel et al. · Clinical Infectious Diseases · 2005 · 461 citations · Full text

A Double‐Blind, Randomized, Controlled Trial of Amphotericin B Colloidal Dispersion versus Amphotericin B for Treatment of Invasive Aspergillosis in Immunocompromised Patients

Raleigh A. Bowden, Pranatharthi Chandrasekar, Mary H. White et al. · Clinical Infectious Diseases · 2002 · 328 citations · Full text

Randomized Placebo‐Controlled Trial of Fluconazole Prophylaxis for Neutropenic Cancer Patients: Benefit Based on Purpose and Intensity of Cytotoxic Therapy

Coleman Rotstein, Eric J. Bow, Michél Laverdière et al. · Clinical Infectious Diseases · 1999 · 266 citations · Full text

Pharmacotherapy, Antimicrobial Chemotherapy, Drug Resistance +16